Navigation Links
New partnership offers outsourced R&D in membrane biology

One of the UK's most successful academic entrepreneurs has teamed up with the University of Leeds to offer outsourced research and development in membrane biology to pharmaceutical, biotech and agrochemical companies.

Dr Tony Marchington, who turned his spin-out company Oxford Molecular into a business worth 450m, will work alongside the Universitys new Centre for Integrative Membrane Biology (CIMB) to broker research contracts with industry, based on Leeds world-class expertise in membrane biology.

Membrane biology research is central to the improved treatment of human disease with pharmaceutical drugs; currently around 75 per cent of current drugs have their effects via membrane proteins(1).

The partnership between CIMB, based at the Universitys Faculty of Biological Sciences, and M2 Ventures - Dr Marchingtons new company set up with finance expert Martin Manning - will offer a co-ordinated expert research resource to industry addressing membrane function at all levels: the biology of single cells through to whole organisms; analysis of protein structure and function; membranes on devices and high throughput interrogation platforms, such as for sensor technologies.

Says Dr Marchington: As the pharma and healthcare industries continue the trend to outsource their fundamental research and early stage development, the natural recipients of this work are universities, such as Leeds, that have both research excellence in these areas and can package and offer that expertise in ways that meet industry requirements.

Its self-evident that Leeds has exceptional breadth of expertise including world-class research capability in membrane biology; and as the market for targeted drugs accelerates, we believe that there will be great demand for their services. With our combined knowledge, experience and contacts, we are in a formidable position to capitalise on the strengths of this partnership.

The partnership was brokered by Leeds Professors Deborah Withington and John Colyer both of whom have extensive commercial experience. Professor Withington said: This partnership has all the hallmarks of something very special and were excited by its potential.


Contact: Jo Kelly
University of Leeds

Related biology news :

1. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
2. New partnership to clear landmines for African Elephants
3. Gut microbes partnership helps body extract energy from food, store it as fat
4. Protein offers way to stop microscopic parasites in their tracks
5. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
6. Gene silencing technique offers new strategy for treating, curing disease
7. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
8. Drug Offers Alternative to Surgical Treatment After Miscarriage
9. Transgenic goats milk offers hope for tackling childrens intestinal disease
10. Engineered skin offers clues to melanoma development
11. GM crop that holds on to its seeds offers higher yields
Post Your Comments:
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
(Date:10/29/2015)... , Oct. 29, 2015 Today, ... a partnership with 2XU, a global leader in ... a smart hat with advanced bio-sensing technology. The ... athletes to monitor key biometrics to improve overall ... partnership, the two companies will bring together the most ...
(Date:10/27/2015)... Oct. 27, 2015 Synaptics Inc. (NASDAQ: SYNA ... that Google has adopted the Synaptics ® ClearPad ... to power its newest flagship smartphones, the Nexus 5X ... --> --> Synaptics ... provide strategic collaboration in the joint development of next ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... be speaking at the following conference, and invited investors ... York, NY      Tuesday, December 1, 2015 at ... York, NY      Tuesday, December 1, 2015 at ... Healthcare Conference, New York, NY ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - Aeterna ... request of IIROC on behalf of the Toronto Stock ... news release there are no corporate developments that would ... --> --> About ... . --> Aeterna Zentaris is ...
Breaking Biology Technology: